Evidence map›Paper›PMID 39404067›Full record

ReviewNucleic acids research2024

Re-appraising the evidence for the source, regulation and function of p53-family isoforms.

Ignacio López, Irene Larghero Valdivia, Borivoj Vojtesek, Robin Fåhraeus, Philip J Coates

Abstract readReview
In one paragraph

Review in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ignacio LópezBiochemistry, Faculty of Science, Universidad de la República, Iguá 4225, Montevideo 11400, Uruguay.ORCID 0000-0001-9669-8906
Irene Larghero ValdiviaBiochemistry, Faculty of Science, Universidad de la República, Iguá 4225, Montevideo 11400, Uruguay.ORCID 0009-0008-5748-433X
Borivoj VojtesekRECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno 65653, Czech Republic.ORCID 0000-0001-6194-3705
Robin FåhraeusRECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno 65653, Czech Republic.ORCID 0000-0003-0402-8492
Philip J CoatesRECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno 65653, Czech Republic.ORCID 0000-0003-1518-6306

Funding

Agencia Nacional de Investigación e Innovación FCE_3_2020_1_161877Cancerforskningsfonden Norr, Cancerfonden, VetenskapsradetCzech Science Foundation GACR 23-05951SEuropean Union and the State Budget of the Czech Republic CZ.02.01.01/00/22_008/0 004 644Ministry of Health MH CZ-DRO MMCIPrograma de Desarrollo de las Ciencias Básicas
6 · The paper itself

Abstract

The p53 family of proteins evolved from a common ancestor into three separate genes encoding proteins that act as transcription factors with distinct cellular roles. Isoforms of each member that lack specific regions or domains are suggested to result from alternative transcription start sites, alternative splicing or alternative translation initiation, and have the potential to exponentially increase the functional repertoire of each gene. However, evidence supporting the presence of individual protein variants at functional levels is often limited and is inferred by mRNA detection using highly sensitive amplification techniques. We provide a critical appraisal of the current evidence for the origins, expression, functions and regulation of p53-family isoforms. We conclude that despite the wealth of publications, several putative isoforms remain poorly established. Future research with improved technical approaches and the generation of isoform-specific protein detection reagents is required to establish the physiological relevance of p53-family isoforms in health and disease. In addition, our analyses suggest that p53-family variants evolved partly through convergent rather than divergent evolution from the ancestral gene.

Indexed as

Alternative SplicingProtein IsoformsTumor Suppressor Protein p53AnimalsEvolution, MolecularGene Expression RegulationHumansRNA, MessengerTranscription Initiation SiteProtein IsoformsRNA, MessengerTumor Suppressor Protein p53

Identifiers

PMID39404067
PMCPMC11551734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.